Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02235623 · ClinicalTrials.gov registry record · NA
Orchidopexy Randomized Clinical Assessment
A NA study, sponsored by Boston Children's Hospital.
- Recruiting
- Registry status
- NA
- Development phase
- 66
- Enrollment target
NCT02235623 is a NA study that is actively recruiting participants, run by Boston Children's Hospital. The registered enrollment target is 66 participants.
The verdict
NCT02235623, a NA study, is actively recruiting participants, sponsored by Boston Children's Hospital.
- RECRUITING
- Registry status
- NA
- Development phase
- 66 participants
- Enrollment target
Study Summary
This is a randomized trial designed to evaluate testicular outcomes after a single stage versus a two-stage surgical procedure to fix an undescended, one-sided testicle located in the abdomen. Also to determine and compare the costs, surgical complications and the health related quality of life for the two procedures. Testicular outcomes will be measured using a scrotal ultrasound 6-12 months after the procedure (after the second stage procedure for those randomized to a 2 stage surgery).
Interventions
- PROCEDURE Single-stage Fowler-Stephens orchidopexy (FSO)
- PROCEDURE Two-stage Fowler-Stephens orchidopexy (FSO)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 66 participants |
| Start Date | 2014-08 |
| Est. Completion | 2030-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02235623
The ClinicalTrials.gov registry entry for NCT02235623 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 66 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Children's Hospital, which has 462 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Single-stage Fowler-Stephens orchidopexy (FSO) is the first listed.
NCT02235623 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02235623 about?
NCT02235623 is a clinical study titled "Orchidopexy Randomized Clinical Assessment". This is a randomized trial designed to evaluate testicular outcomes after a single stage versus a two-stage surgical procedure to fix an undescended, one-sided testicle located in the abdomen. Also to determine and compare the costs, surgical complications and the health related quality of life for ...
What is the current status of trial NCT02235623?
This trial is currently recruiting. It is a NA study. The enrollment target is 66 participants. The study started on 2014-08. Estimated completion is 2030-12-31.
What interventions are being tested in trial NCT02235623?
The interventions under investigation include: Single-stage Fowler-Stephens orchidopexy (FSO) (PROCEDURE), Two-stage Fowler-Stephens orchidopexy (FSO) (PROCEDURE).
Who is sponsoring clinical trial NCT02235623?
This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.